NeuroMetrix Receives FDA 510(k) Clearance for Advance

Long beleaguered NeuroMetrix, which has seen its stock price erode as officials investigate the marketing and misuse of its NC-stat System, received FDA 510(k) clearance for the Advance System this week. Shares of the Waltham, MA-based company nearly doubled on the news, to a high of $3.06 on...

[Video Profile] Interview with Dr. Randal Chase, CEO of ImmunoVaccine Technologies

ImmunoVaccine Technologies (IVT) is a private biotechnology company developing therapeutic cancer and infectious disease vaccines. VacciMax technology is based on a novel approach to the use of liposomes. While liposomes typically contribute only marginally to the production of an immune response, IVT has...

Merit Medical: Shows Resilience in Faltering Economy; Positioned for Continued Growth

The healthcare equipment sector has a history of resilience. The sector remained strong during the economic downturn earlier this decade and appears to be holding its own now. An aging demographic virtually guarantees increased demand for healthcare supplies. Not surprisingly, the sector is also highly...

Yulex Receives FDA 510(k) Clearence for Novel Rubber Glove

Latex glove use increased dramatically in the eighties largely as an outgrowth of the AIDS epidemic. Almost unheard of 20 years ago, researchers now estimate that 8% – 12% of healthcare workers have developed allergies to traditional latex. In one well-cited study of blood donors, more than 6% had...

Biophan Moves Forward with Myotech CSS Development

Pittsford, NY-based Biophan Technologies, will move forward with the next phase of the Myotech Circulatory Support System (CSS) engineering and regulatory development program. The company’s board released $2 million to support efforts which will bring the product closer to commercialization. According to...

OccuLogix Looks to Tears, Hopes to Survive Difficulties

OccuLogix, which traded as high as $1.63 just one year ago, has seen its share price erode as investors lose confidence in the company and its management. OccuLogix has consistently failed to execute general corporate strategy. The company, which faces NASDAQ delisting, opened at $.22 this morning. In 2007,...

Maryland Medicaid Approves ActiPatch Technology for Kidney Compromised Patients

Patients with kidney disease often avoid common pain relievers like aspirin, ibuprofen and naproxen. These medications have the potential to exacerbate existing conditions and create life-threatening drug interactions. As an alternative to drug-based relief for kidney-compromised patients, Maryland Medicaid...

[Video Profile] Interview with Leah Sparks, VP Business Development of DNA Direct

Medical professional societies have mandated that genetic tests be ordered by a physician and interpreted by a genetic counselor, geneticist, or other specialist. In some states, genetic testing must be accompanied by an in-person genetics evaluation or genetic counseling appointment. This approach is...